Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

358 ARTÍCULOS , VIENDO DEL 226 AL 240

Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease

Hernandez L, Ozen A, DosSantos R, Getsios D.

Pharmacoeconomics. 2016 Jul;34(7):681-707. doi: 10.1007/s40273-016-0392-1.

A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome

Iulita MF, Caraci F, Cuello AC.

CNS Neurol Disord Drug Targets. 2016;15(4):434-47. doi: 10.2174/1871527315666160321104916.

Alzheimer's Disease and Autistic Spectrum Disorder: Is there any Association?

Khan SA, Khan SA, Narendra AR, Mushtaq G, Zahran SA, Khan S, Kamal MA.

CNS Neurol Disord Drug Targets. 2016;15(4):390-402. doi: 10.2174/1871527315666160321104303.

Association between Antipsychotic Drugs and Mortality in Older Persons with Alzheimer's Disease: A Systematic Review and Meta-Analysis

Zhai Y, Yin S, Zhang D.

J Alzheimers Dis. 2016 Mar 31;52(2):631-9. doi: 10.3233/JAD-151207.

Effects of Citalopram on Neuropsychiatric Symptoms in Alzheimer's Dementia: Evidence From the CitAD Study

Leonpacher AK, Peters ME, Drye LT, Makino KM, Newell JA, Devanand DP, Frangakis C, Munro CA, Mintzer JE, Pollock BG, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, Porsteinsson AP; CitAD Research Group.

Am J Psychiatry. 2016 May 1;173(5):473-80. doi: 10.1176/appi.ajp.2016.15020248. Epub 2016 Apr 1.

Pharmacological Management of Agitation and Aggression in Alzheimer's Disease: A Review of Current and Novel Treatments

Liu CS, Ruthirakuhan M, Chau SA, Herrmann N, Carvalho AF, Lanctôt KL.

Curr Alzheimer Res. 2016;13(10):1134-44. doi: 10.2174/1567205013666160502122933.

Adrenergic Drugs Blockers or Enhancers for Cognitive Decline ? What to Choose for Alzheimer's Disease Patients?

Femminella GD, Leosco D, Ferrara N, Rengo G.

CNS Neurol Disord Drug Targets. 2016;15(6):665-71. doi: 10.2174/1871527315666160518123201.

Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies

Zolochevska O, Taglialatela G.

Curr Pharm Des. 2016;22(26):4063-8. doi: 10.2174/1381612822666160518142110.

The Rationale for Insulin Therapy in Alzheimer's Disease

Ribarič S.

Molecules. 2016 May 26;21(6):689. doi: 10.3390/molecules21060689.

Identifying and Managing Pain in People with Alzheimer's Disease and Other Types of Dementia: A Systematic Review

Husebo BS, Achterberg W, Flo E.

CNS Drugs. 2016 Jun;30(6):481-97. doi: 10.1007/s40263-016-0342-7.

Improving Memory and Cognition in Individuals with Down Syndrome

Rafii MS.

CNS Drugs. 2016 Jul;30(7):567-73. doi: 10.1007/s40263-016-0353-4.

Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis

Lin PJ, Zhong Y, Fillit HM, Chen E, Neumann PJ.

J Am Geriatr Soc. 2016 Aug;64(8):1549-57. doi: 10.1111/jgs.14227. Epub 2016 Jun 13.

Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure

Pasqualetti G, Caraccio N, Dell Agnello U, Monzani F.

Recent Pat Endocr Metab Immune Drug Discov. 2016;10(1):4-10. doi: 10.2174/1872214810666160701110509.

Antihypertensiva-Stopp ohne Effekt auf die kognitive Funktion alter Menschen

Zechmann S.

Praxis (Bern 1994). 2016 Jul;105(15):917-8. doi: 10.1024/1661-8157/a002417.

The association of renin-angiotensin system blockade use with the risks of cognitive impairment of aging and Alzheimer's disease: A meta-analysis

Zhuang S, Wang HF, Wang X, Li J, Xing CM.

J Clin Neurosci. 2016 Nov;33:32-38. doi: 10.1016/j.jocn.2016.02.036. Epub 2016 Jul 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias